About
Our Mission
Leadership
Partners
Our Technologies
TALEN® Technology
Gene Editing
PulseAgile Technology
Patents
Pipeline
Products
Clinical Indications
Manufacturing
Investors
Press Releases
Corporate presentation & ESG report
Scientific Presentations
Scientific Publications
Events and Webcasts
2021 Cellectis Innovation Days
Stock Information
Corporate Governance
Governance Documents
Board of Directors & Committee Members
Shareholders Meeting
SEC Filings
Contact
IR Inquiries
Email Alerts
Investor FAQ
Careers
Our Culture
Job Opportunities
Contact us
fr
Scientific Presentations
Press releases
Corporate presentation
Scientific Presentations
Scientific Publications
Events and webcasts
Stock information
SEC filings
Financial Statements
Regulated information
Voting Rights & Share Capital
ATM Program
General meetings
Governance
The board and committee members
Corporate governance documents
FAQ
IR Inquiry
All
2024
2023
2022
2021
05
Nov 2024
16:30 E.S.T.
Breaking Barriers in Solid Tumors with SMART allogeneic CAR T-cells
Download the PDF file
22
Oct 2024
02:00 E.S.T.
Controlling C-to-T editing with TALE base editors - ESGCT 2024 - Poster Presentation
Download the PDF file
22
Oct 2024
02:00 E.S.T.
CIRCULARIZATION OF SINGLE-STRANDED DNA TEMPLATE IMPROVES TALEN-MEDIATED GENE INSERTION IN LONG-TERM HSC - ESGCT 2024 - Poster Presentation
Download the PDF file
10
May 2024
15:27 E.S.T.
Circularization of Non-Viral Single-Strand DNA Template for Gene Correction and Gene Insertion Improves Editing Outcomes in HSPCs - ASGCT 2024 - Poster Presentation
Download the PDF file
09
May 2024
08:19 E.S.T.
Intron Editing of HSPC Enables Lineage-Specific Expression of Therapeutics - ASGCT 2024 - Poster Presentation
Download the PDF file
24
Jan 2024
04:20 E.S.T.
Comprehensive Analysis of the Editing Window of TALE Base Editors - Keystone Symposia “Precision Genome Engineering” - Poster Presentation
Download the PDF file
24
Jan 2024
04:19 E.S.T.
TALEN®-edited Allogeneic Inducible Dual CAR T-cells Enable Effective Targeting of Solid Tumors - Keystone Symposia “Emerging Cellular Therapies” - Poster Presentation
Download the PDF file
24
Jan 2024
04:11 E.S.T.
Preclinical efficacy of PD-L1/TGF-beta resistant MUC1-CAR T-cells with inducible IL12 against triple-negative breast cancer - Keystone Symposia “Emerging Cellular Therapies” - Poster Presentation
Download the PDF file
12
Dec 2023
10:48 E.S.T.
Updated Results of the Phase I BALLI-01 Trial of UCART22 Process 2 (P2), an Anti-CD22 Allogeneic CAR-T-Cell Product Manufactured by Cellectis Biologics, in Patients with Relapsed or Refractory (R/R) CD22+ (B-ALL) - ASH 2023 - Poster Presentation
Download the PDF file
12
Dec 2023
10:44 E.S.T.
Preliminary Results of NatHaLi-01: A First-In-Human Phase I/IIa Study of UCART20x22, a Dual Allogeneic CAR-T Cell Product Targeting CD20 and CD22, in Relapsed or Refractory (R/R) Non-Hodgkin Lymphoma (NHL) - ASH 2023 - Poster Presentation
Download the PDF file
1
2
3
Next